Randomized, Double-Blind, Placebo-Controlled Trial Demonstrates the Efficacy and Safety of Oral Aripiprazole for the Treatment of Tourette's Disorder in Children and Adolescents

Objectives: Aripiprazole modulates dopaminergic and serotonergic pathways that may play a role in the pathogenesis of Tourette's disorder (TD). This trial evaluated the efficacy and safety of oral aripiprazole in the suppression of tics in children and adolescents with TD. Methods: This phase 3...

Descripción completa

Detalles Bibliográficos
Autores principales: Sallee, Floyd, Kohegyi, Eva, Zhao, Joan, McQuade, Robert, Cox, Kevin, Sanchez, Raymond, van Beek, Alet, Nyilas, Margaretta, Carson, William, Kurlan, Roger
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mary Ann Liebert, Inc. 2017
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5689110/
https://www.ncbi.nlm.nih.gov/pubmed/28686474
http://dx.doi.org/10.1089/cap.2016.0026

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5689110/
https://www.ncbi.nlm.nih.gov/pubmed/28686474
http://dx.doi.org/10.1089/cap.2016.0026

Ejemplares similares